← all works
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet
- Topic
- Cervical Cancer and HPV Research
- Field
- Medicine
- Canadian institutions
- University of ManitobaUniversity of Alberta
- Funders
- GlaxoSmithKline
- Keywords
- MedicineCohortInterim analysisCervical cancerVaccine efficacyClinical endpointVaccine trialPopulationHPV infectionInternal medicineCervical intraepithelial neoplasiaVaccinationHPV vaccinesClinical trialOncologyCancerImmunology
- Has abstract in OpenAlex
- no